Brief Summary:
One in three American adults have prediabetes, and up to 70% of adults with prediabetes eventually develop type 2 diabetes. With the high cost of treating diabetes, cost-effective approaches are needed to reduce the incidence of diabetes. One new strategy may be to change when people eat. Studies in rodents suggest that a form of intermittent fasting that limits eating to a short time period each day and involves fasting for the rest of the day (time-restricted feeding; TRF) improves blood sugar control and cardiovascular health. Preliminary studies suggest that TRF also improves blood sugar, weight loss, and cardiovascular health in humans. This study will be the first full-scale, controlled feeding trial to determine whether TRF can improve 24-hour blood sugar control, 24-hour blood pressure, and cardiovascular disease risk factors even when food intake is matched to the control group. This clinical trial will also determine whether the benefits of TRF depend on the time of day that people eat. Participants will be assigned to one of three groups: (1) ‘Early TRF’ (eat between ~8 am-3 pm), (2) ‘Mid-day TRF’ (eat between ~1 pm – 8 pm), or (3) Control Schedule (~8 am – 8 pm) for 10 weeks. All food will be provided and matched between groups.
Condition or disease
Intervention/treatment
Phase
PreDiabetes
Behavioral: Early Time-Restricted Feeding Behavioral: Mid-day Time-Restricted Feeding Behavioral: Control Schedule
Not Applicable
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.